Latest Articles
‘Important step forward’ in endometrial cancer treatment - Medical Republic
‘Important step forward’ in endometrial cancer treatment Medical Republic
Published: May 26, 2025, 4:46 a.m.
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study - Cureus
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study Cureus
Published: May 24, 2025, 12:37 a.m.
Dr Lantsman on Future Directions for Evaluating Dostarlimab/Chemo in Endometrial Cancer - OncLive
Dr Lantsman on Future Directions for Evaluating Dostarlimab/Chemo in Endometrial Cancer OncLive
Published: May 23, 2025, 7:05 p.m.
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fuelling push into phase 3 - Fierce Biotech
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fuelling push into phase 3 Fierce Biotech
Published: May 23, 2025, 1:22 p.m.
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fueling push into phase 3 - Fierce Biotech
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fueling push into phase 3 Fierce Biotech
Published: May 23, 2025, 1:22 p.m.
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment - TipRanks
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment TipRanks
Published: May 23, 2025, 10:59 a.m.
Breakthrough Cancer Data: Genmab Reveals First Rina-S Results for Deadly Endometrial Cancer at ASCO 2025 - Stock Titan
Breakthrough Cancer Data: Genmab Reveals First Rina-S Results for Deadly Endometrial Cancer at ASCO 2025 Stock Titan
Published: May 22, 2025, 9:05 p.m.
Navigating complexities of polymorphic microbiomes in endometrial cancer - Nature
Navigating complexities of polymorphic microbiomes in endometrial cancer Nature
Published: May 22, 2025, 6:42 p.m.
ASCO 2025: A Preview of Advancements in Endometrial Cancer - Medscape
ASCO 2025: A Preview of Advancements in Endometrial Cancer Medscape
Published: May 21, 2025, 5:15 p.m.
PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer - Medical Dialogues
PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer Medical Dialogues
Published: May 21, 2025, 3 p.m.
Link copied to clipboard!